ENDRA Life Sciences (NDRA) Research & Development (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Research & Development of $776410.0 for Q1 2026, up 46.86% year-over-year from $528685.0 in Q1 2025, and up 52.8% quarter-over-quarter from $508137.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Research & Development (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Research & Development data on file, last reported at $776410.0 in Q1 2026.
- Research & Development for Q1 2026 came in at $776410.0, up 46.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (down 21.65% YoY), and the FY2025 annual result was $1.8 million, down 42.01% from the prior year.
- Research & Development climbed to $776410.0 in Q1 2026 per NDRA's latest filing, from $508137.0 in the prior quarter.
- Over five years, Research & Development peaked at $1.8 million in Q2 2022 and troughed at $381061.0 in Q2 2025.
- A 5-year average of $1.0 million and a median of $794444.0 in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development soared 55.99% in 2022, then tumbled 65.17% in 2023.
- A 5-year view of Research & Development shows it stood at $1.7 million in 2022, then plunged by 65.17% to $579350.0 in 2023, then gained by 10.12% to $637957.0 in 2024, then decreased by 20.35% to $508137.0 in 2025, then jumped by 52.8% to $776410.0 in 2026.
- Business Quant data shows NDRA's Research & Development at $776410.0 in Q1 2026, $508137.0 in Q4 2025, and $432113.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 96.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 336.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 387.00 Mn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 65.79 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 126.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | - |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 210.70 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 240.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 51.28 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | 776,410.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 776,410.00 |
| Dec 31, 2025 | 508,137.00 |
| Sep 30, 2025 | 432,113.00 |
| Jun 30, 2025 | 381,061.00 |
| Mar 31, 2025 | 528,685.00 |
| Dec 31, 2024 | 637,957.00 |
| Sep 30, 2024 | 794,444.00 |
| Jun 30, 2024 | 716,366.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 579,350.00 |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 1.83 Mn |
| Jun 30, 2022 | 1.85 Mn |
| Mar 31, 2022 | 1.21 Mn |
| Dec 31, 2021 | 1.42 Mn |
| Sep 30, 2021 | 1.17 Mn |
| Jun 30, 2021 | 1.74 Mn |